Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Side Effects of Long‐Term Proton Pump Inhibitor Use: A Review
Peter Haastrup, Wade Thompson, Jens Søndergaard, et al.
Basic & Clinical Pharmacology & Toxicology (2018) Vol. 123, Iss. 2, pp. 114-121
Open Access | Times Cited: 177

Showing 1-25 of 177 citing articles:

Adverse Effects Associated with Proton Pump Inhibitor Use
Marcel Yibirin, Diana De Oliveira, Roberto J. Valera, et al.
Cureus (2021)
Open Access | Times Cited: 111
Anabolic–androgenic steroids: How do they work and what are the risks?
Peter Bond, Diederik L. Smit, Willem de Ronde
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 83
ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats
Stanley L. Marks, Peter H Kook, Mark G. Papich, et al.
Journal of Veterinary Internal Medicine (2018) Vol. 32, Iss. 6, pp. 1823-1840
Open Access | Times Cited: 111
Peptic ulcer disease
Emma Sverdén, Lars Agréus, Jason Dunn, et al.
BMJ (2019), pp. l5495-l5495
Closed Access | Times Cited: 79
Overview of Helicobacter pylori Infection: Clinical Features, Treatment, and Nutritional Aspects
Merve Öztekin, Birsen Yılmaz, Duygu Ağagündüz, et al.
Diseases (2021) Vol. 9, Iss. 4, pp. 66-66
Open Access | Times Cited: 78
Equine Gastric Ulcer Syndrome: An Update on Current Knowledge
Jessica Vokes, A Lovett, B. W. Sykes
Animals (2023) Vol. 13, Iss. 7, pp. 1261-1261
Open Access | Times Cited: 36
Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis
Sébastien Lopes, L. Pabst, Anne Dory, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Emerging factors affecting peri‐implant bone metabolism
Ángel Ínsua, Pablo Galindo‐Moreno, Richard J. Miron, et al.
Periodontology 2000 (2023) Vol. 94, Iss. 1, pp. 27-78
Open Access | Times Cited: 22
Proton pump inhibitors alter gut microbiota by promoting oral microbiota translocation: a prospective interventional study
Xue Xiao, Xian Zhang, Jin Wang, et al.
Gut (2024) Vol. 73, Iss. 7, pp. 1098-1109
Closed Access | Times Cited: 13
Proton Pump Inhibitors and Cancer Risk: A Comprehensive Review of Epidemiological and Mechanistic Evidence
Ibrahim O. Sawaid, Abraham O. Samson
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1970-1970
Open Access | Times Cited: 9
When does proton pump inhibitor treatment become long term? A scoping review
Peter Haastrup, Dorte Ejg Jarbøl, Wade Thompson, et al.
BMJ Open Gastroenterology (2021) Vol. 8, Iss. 1, pp. e000563-e000563
Open Access | Times Cited: 40
SAFETY OF LONG-TERM PROTON PUMP INHIBITORS: FACTS AND MYTHS
Décio Chinzon, Gerson Domingues, Nívia Jardim Tosetto, et al.
Arquivos de Gastroenterologia (2022) Vol. 59, Iss. 2, pp. 219-225
Open Access | Times Cited: 31
Vonoprazan as a Long-term Maintenance Treatment for Erosive Esophagitis: VISION, a 5-Year, Randomized, Open-label Study
Naomi Uemura, Yoshikazu Kinoshita, Ken Haruma, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 6
Hypomagnesemia Causing Convulsions in a Patient Taking a Proton Pump Inhibitor: A Case Report
Takanobu Sato, Ryogo Ohashi, Katsuya Konishi, et al.
Cureus (2025)
Open Access
Assessment of the efficacy of on-demand tegoprazan therapy in gastroesophageal reflux disease through a randomized controlled trial
Sun Hyung Kang, Hee Seok Moon, Jae Kyu Sung, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Practices and knowledge of community pharmacists towards the use of proton pump inhibitors: a cross-sectional study in Jordan
Lobna Gharaibeh, Mariam Ahmad Alameri, Mai I. AL-Hawamdeh, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e085589-e085589
Open Access
Association between CYP2C19 polymorphism and proton pump inhibitors adverse drug reactions: a narrative review
Ibrahim Aa, Kazeem B. Yusuff, Ahmed Awaisu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Immediate and delayed hypersensitivity reactions to Proton pump inhibitors: A review article
Vahida Ćorović, Irfan Ćorović, Vahid Ademović, et al.
SANAMED (2025), Iss. 00, pp. 80-80
Open Access
Anti-inflammatory effects of Esomeprazole in septic lung injury by mediating endoplasmic reticulum stress
Peng Wang, Hui Li, Wencheng Wu
Journal of Bioenergetics and Biomembranes (2025)
Closed Access
Protective mechanism of apigenin in proton pump inhibitor-associated progressive cognitive impairment in adult zebrafish via targeting GSK-3β pathway
Anjalee Bhratee, Dhrita Chatterjee, Ramandeep Kaur, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 4
Closed Access
Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer
Nele Brusselaers, Jesper Lagergren, Lars Engstrand
Cancer Epidemiology (2019) Vol. 62, pp. 101585-101585
Open Access | Times Cited: 44
Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system
Bin Wu, Dan Li, Ting Xu, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 37
A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data
Bin Wu, Qiaozhi Hu, Fangyuan Tian, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 32
Reduce unnecessary use of proton pump inhibitors
Barbara Farrell, Elliot Lass, Paul Moayyedi, et al.
BMJ (2022), pp. e069211-e069211
Closed Access | Times Cited: 26
Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies
Chieh-Chen Wu, Mao-Hung Liao, Woon‐Man Kung, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2262-2262
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top